Author:
Duman Berna Bozkurt,Şahin Berksoy,Ergin Melek,Guvenc Birol
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference18 articles.
1. Smith MR. Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene. 2003;22:7359–68.
2. Davis TA, Grillo-Lopez AJ, White CA, McLaughlin P, Czucman MS, Link BK, Maloney DG, Weaver RL, Rosenberg J, Levy R. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin’s lymphoma: safety and efficacy of re-treatment. J Clin Oncol. 2000;18:3135–43.
3. Kinoshita T, Nagai H, Murate T, Saito H. CD20 negative relapse in B-cell lymphoma after treatment with rituximab. J Clin Oncol. 1998;16:3916.
4. Grillo-Lopez AJ, Kunkel L. Therapy of B-cell lymphoma with anti-CD20 antibodies can result in loss of CD20 antigen expression. Clin Cancer Res. 2000;6:317–8.
5. Schmitz K, Brugger W, Weis B, Kaiserling E, Kanz L. Clonal selection of CD20 negative non Hodgkin’s lymphoma cells after treatment with anti CD20 antibody rituximab. Br J Haematol. 1999;106:571–2.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献